Conjunctivitis, Allergic  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00884585: Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis

Completed
3
176
US, Canada, Europe, RoW
Cyclosporine Vehicle, Cyclosporine 0.010%
Allergan
Atopic Conjunctivitis
10/10
07/11

Download Options